Therapeutic Potential of Kappa-Opioids Against Cocaine - 1

National Institutes of Health (NIH)

Status: Completed

Conditions: Cocaine-Related Disorders

Study type: Observational

Funder types: NIH

Identifiers

NCT00000323

NIDA-10753-1

R01-10753-1

Details and patient eligibility

About

The purpose of this study is to characterize the effects of enadoline compared to hydromorphone and butorphanol.

Sex: All

Ages: 21 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

opiate experienced, healthy

Exclusion criteria

physical dependence on opioids, barbiturates or alcohol